[1]Pokhrel B, Leslie S W, Levine S N. Primary hyperparathyroidism[M]. Treasure Island (FL): StatPearls Publishing, 2022.
[2]Bilezikian J P, Bandeira L, Khan A, et al. Hyperparathyroidism[J]. Lancet, 2018, 391(10116): 168-178.
[3]中华医学会外科学分会甲状腺及代谢外科学组, 中国研究型医院学会甲状旁腺及骨代谢疾病专业委员会. 原发性甲状旁腺功能亢进症围手术期处理中国专家共识(2020版)[J]. 全科医学临床与教育, 2020, 18(7): 579-583.
[4]王曼, 候亚琴, 崔碧霄, 等. 99mTc-MIBI SPECT/CT显像在原发性甲状旁腺功能亢进症术前诊断中的应用价值[J]. 首都医科大学学报, 2022, 43(6): 861-866.
[5]郭月红, 黄京伟, 常玉婷, 等. 99mTc-MIBI平面显像及断层显像诊断原发性甲状旁腺功能亢进的效能评价[J]. 首都医科大学学报, 2022, 43(6): 873-879.
[6]Zarei A, Karthik S, Chowdhury F U, et al. Multimodality imaging in primary hyperparathyroidism[J]. Clin Radiol, 2022, 77(6): e401-e416.
[7]Kattar N, Migneron M, Debakey M S, et al. Advanced computed tomographic localization techniques for primary hyperparathyroidism: a systematic review and meta-analysis[J]. JAMA Otolaryngol Head Neck Surg, 2022, 148(5): 448-456.
[8]Boudousq V, Guignard N, Gilly O, et al. Diagnostic performance of cervical ultrasound, 99mTc-Sestamibi scintigraphy, and Contrast-Enhanced 18F-Fluorocholine PET in primary hyperparathyroidism[J]. J Nucl Med, 2022, 63(7): 1081-1086.
[9]Blanco-Saiz I, Goñi-Gironés E, Ribelles-Segura M J, et al. Anda-Apiñániz E. Preoperative parathyroid localization. Relevance of MIBI SPECT-CT in adverse scenarios[J]. Endocrinol Diabetes Nutr (Engl Ed), 2023, 70 Suppl 2: 35-44.
[10]Salhi H, Bouziane T, Maaroufi M, et al. Primary hyperparathyroidism: correlation between cervical ultrasound and MIBI scan[J]. Ann Afr Med, 2022, 21(2): 161-164.
[11]Schachter P P, Issa N, Shimonov M, et al. Early, postinjection MIBI-SPECT as the only preoperative localizing study for minimally invasive parathyroidectomy[J]. Arch Surg, 2004, 139(4): 433-437.
[12]宋桉, 王鸥, 刘春晓, 等. 甲状旁腺四维CT在原发性甲状旁腺功能亢进症术前定位中的诊断价值[J]. 中华内科杂志, 2020, 59(10): 788-795.
[13]Mahajan S, Schoder H. Ectopic undescended parathyroid adenoma-SPECT/CT avoids false-negative interpretation on 99mTc-MIBI dual-phase scintigraphy[J]. Clin Nucl Med, 2018, 43(3): 199-200.
[14]来益, 沈宇玲, 周佳青. 99Tc m-MIBI SPECT/CT阴性的颌下异位甲状旁腺腺瘤1例[J]. 中华耳鼻咽喉头颈外科杂志, 2023, 58(2): 157-159.
[15]Kedarisetty S, Fundakowski C, Ramakrishnan K, et al. Clinical value of Tc99m-MIBI SPECT/CT versus 4D-CT or US in management of patients with hyperparathyroidism[J]. Ear Nose Throat J, 2019, 98(3): 149-157.
[16]Zhang R Q, Zhang Z W, Huang P B, et al. Diagnostic performance of ultrasonography, dual-phase 99mTc-MIBI scintigraphy, early and delayed 99mTc-MIBI SPECT/CT in preoperative parathyroid gland localization in secondary hyperparathyroidism[J]. BMC Med Imaging, 2020, 20(1): 91.
[17]Peng Y, Pan G, Zhao B, et al. Incremental value of 99mTc-MIBI single-photon emission computed tomography/computed tomography fusion imaging for the diagnosis of secondary hyperparathyroidism[J]. Nucl Med Commun, 2023, 44(9): 767-771.
[18]Petranovic′ Ovariek P, Giovanella L, Carrió Gasset I, et al. The EANM practice guidelines for parathyroid imaging[J]. Eur J Nucl Med Mol Imaging, 2021, 48(9): 2801-2822.
[19]Szczepanek-Parulska E, Filipowicz D, Czepczyński R, et al. Clinical, biochemical, and sonographic factors influencing performance of parathormone washout measurement vs. 99mtc-mibi scintigraphy in the preoperative diagnostics of parathyroid adenomas[J]. J Clin Med, 2023, 12(12): 4097.
[20]Zhu C Y, Sturgeon C, Yeh M W. Diagnosis and management of primary hyperparathyroidism[J]. JAMA, 2020, 323(12): 1186-1187.
|